Latest Spago Nanomedical News & Updates

See the latest news and media coverage for Spago Nanomedical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Spago Nanomedical

Clinical-stage nanomedicine developer for cancer diagnosis and treatment

spagonanomedical.se
Headquarters
Lund, Sweden
Founded year
2007
Company type
Public company
Number of employees
15–50
Industry
Biotechnology & Medical Research

Last updated

Latest news about Spago Nanomedical

In short: Spago Nanomedical completed phase I of its Tumorad-01 study and raised SEK 15 million through a rights issue to fund clinical research.

Company announcements

Spago Nanomedical

Spago Nanomedical resolves on a SEK 16 million rights issue

Proceeds will fund phase I completion and phase IIa preparation of Tumorad-01 study; major shareholders committed to about 64 percent of the issue.

Unlock all announcements with a

Media coverage

Affärsvärlden

Good backing in Spago's rights issue

Spago Nanomedical has released the information document for its rights issue of SEK 16.2 million. The Emissions Guide raises one positive and two negative flags.

Yahoo Finance

Spago Nanomedical Publishes the Annual Report for 2025

LUND, SE / ACCESS Newswire / May 19, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical's annual report for 2025 is from today available at the...

Unlock all articles with a

Never miss news about Spago Nanomedical

Track Spago Nanomedical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Spago Nanomedical competitors & trending companies

Browse news for competitors to Spago Nanomedical and other trending companies.